Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JE.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JE.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JE.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.1.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.1.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XCKEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XCKEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCKECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XCKECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCKEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCKEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCKENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GN.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GN.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GN.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GN.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.7.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-15090.2South Korea
DV.7.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.7.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-16141.5Germany
DV.7.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.7.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-12594.2China
DV.7.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XCLEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCLECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCLECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used